DYNAMK CAPITAL
Dynamk Capital invests in innovative tools and technologies that are critical for the discovery, development and production of life-saving therapies.We partner with life science visionaries whose market-defining ideas are shaping the future of how therapeutics are being developed, increasing access for patients, and reducing costs.
DYNAMK CAPITAL
Industry:
Biotechnology Life Science
Founded:
2017-09-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Google Universal Analytics Global Site Tag
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
PCI Pharma Services
PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-02 | Vernal Biosciences | Dynamk Capital investment in Venture Round - Vernal Biosciences | 21 M USD |
| 2022-04-27 | Bionter | Dynamk Capital investment in Seed Round - Bionter | 3 M USD |
| 2022-01-19 | Xcell Biosciences | Dynamk Capital investment in Series B - Xcell Biosciences | 27.5 M USD |
| 2021-12-29 | Curi Bio | Dynamk Capital investment in Series A - Curi Bio | 10 M USD |
| 2021-10-04 | Virica Biotech | Dynamk Capital investment in Series A - Virica Biotech | N/A |
| 2021-09-29 | Envisagenics | Dynamk Capital investment in Series A - Envisagenics | 19.18 M USD |
| 2021-06-17 | Vectron Biosolutions | Dynamk Capital investment in Series A - Vectron Biosolutions | 2.7 M USD |
| 2021-06-15 | Lightspeed Microscopy | Dynamk Capital investment in Series A - Lightspeed Microscopy | 4 M USD |
| 2021-03-18 | Curi Bio | Dynamk Capital investment in Series A - Curi Bio | 6 M USD |
| 2020-10-01 | Lucid Scientific | Dynamk Capital investment in Seed Round - Lucid Scientific | 3 M USD |
More informations about "Dynamk Capital"
Team — Dynamk Capital
Our portfolio companies benefit from the active engagement and high level of commitment that Dynamk Capital provides. We work side by side with management teams to identify and …See details»
Dynamk Capital - Crunchbase Investor Profile
Venture fund focused entirely on Life Sciences Industrials - tools, technologies and services fundamental to biopharma. Dynamk Capital invests in early-stage biotechnology, medical, and life science companies, focusing on the United …See details»
Jessica Davis — Dynamk Capital
Jessica joined Dynamk Capital in June 2020 as the summer associate supporting deal flow, conducting diligence, analyzing targeted market opportunities, and assisting internal firm management. ... InSite Fellow; Vice President, Columbia …See details»
Dynamk Capital Company Profile | Management and Employees …
Dynamk Capital Profile and History. Dynamk Capital is a growth equity and venture capital firm focused on life sciences industrials. Dynamk's investment strategy is centered on identifying …See details»
Dynamk Capital - Investments, Portfolio & Company Exits
Dynamk Capital has made 6 diversity investments. Their most recent diversity investment was on Sep 27, 2023, when CellFE raised. obfuscated. obfuscated. ... Which industries has this …See details»
Dynamk Capital investment portfolio | PitchBook
Dynamk Capital's latest investment was on 14-Jun-2024 in Xcell Biosciences, a company within the Discovery Tools (Healthcare) industry. Data Transparency. Meet our data hygiene team. …See details»
Dynamk Capital - Massinvestor Venture Capital and Private Equity …
Dynamk Capital invests in innovative tools and technologies that are critical for the discovery, development and production of life-saving therapies. Dynamk targets Early Stage companies …See details»
Dynamk Capital's Leadership Team Team - The Org
The leadership team at Dynamk Capital has a wealth of experience in the venture capital industry. They have worked with some of the biggest names in the business, and have a deep understanding of what it takes to succeed in this …See details»
Dynamk Capital - Funding, Financials, Valuation & Investors
Dynamk Capital . Connect to CRM . Save . Summary. Financials. Investments. People. Technology. Signals & News. Similar Companies. Highlights. Funds 1. Funding. Dynamk …See details»
How Is Dynamk Capital Facing the Future of Healthcare?
Sep 29, 2020 How is Dynamk Preparing to Face the Future of Healthcare? Our mission is to fund the future of life sciences. In real terms, this means we provide working capital and …See details»
How Does Dynamk Capital Envision the Future of the …
Dec 9, 2020 Dynamk Capital, one of That's Nice's Road to 2021 sponsors, discusses how the company is envisioning the future of the pharma/biopharma industry. Our team is incredibly …See details»
Daniella Kranjac - Dynamk Capital
As Vice President of the organization, Daniella established a high growth company with significant brand recognition, and led the group to a successful exit and acquisition by GE Healthcare in …See details»
Dynamk Capital - Overview, News & Similar companies - ZoomInfo
Jun 26, 2023 Who is Dynamk Capital. Dynamk Capital is a growth equity and venture capital firm focused on life sciences industrials. Dynamk's investment strategy is centered on identi fying …See details»
Dynamk Capital - Capboard
Dynamk Capital is a venture capital firm that invests in early-stage technology companies. Their mission is to help entrepreneurs build and grow successful businesses. They are focused on …See details»
Dynamk Capital Portfolio Companies — Dynamk Capital
Jun 29, 2020 Dynamk Capital works with entrepreneurs and innovators to accelerate start-ups in Life Science Industrials, providing fundamental technologies and services to biopharma. …See details»
Daniella Kranjac - Founding Partner @ Dynamk Capital - Crunchbase
Daniella Kranjac is the Founding Partner of Dynamk Capital, LLC, founded in 2017 to support early and growth stage life science companies. Daniella has deep domain experience in life …See details»
SeniorsPlus launches $5.5 million capital ... - Lewiston Sun Journal
20 hours ago With $1.5 million in federal funds, thanks to U.S. Sens. Susan Collins and Angus King, a $900,000 grant from Maine Connectivity Authority, funds from Androscoggin and …See details»
Dynamk Capital Content
Dynamk Capital Content . Q4 2023 Quarterly Insights. Dynamk Capital March 5, 2024. Q3 2023 Quarterly Insights. Dynamk Capital October 24, 2023. Q2 2023 Quarterly Insights. Dynamk …See details»
Dynamk Capital - Contacts, Employees, Board Members
Dynamk Capital has 4 current employee profiles, including Principal Sebastien Latapie. Dynamk Capital has 2 board members and advisors, including Anthony J. Maddaluna. Contacts. Edit …See details»
News - Dynamk Capital
Dynamk Capital August 2, 2023. Alpenglow Biosciences CEO, Nick Reder Featured in Recent Pharma's Almanac Interview. Dynamk Capital July 17, 2023. Vernal Biosciences Announces …See details»